Lunit’s new collaboration with Daiichi Sankyo integrates AI-driven digital pathology tools into oncology translational ...

Seven scientists with the Fred Hutch/University of Washington/Seattle Children’s Cancer Consortium received another year of ...

Lunit Announces Collaboration with Daiichi Sankyo to Advance AI-Driven Biomarker Discovery and Translational Oncology ...

Dr. Wen-Han Chang, corresponding author, added, “The work highlights why biomarkers cannot be interpreted in isolation. Tumor context—immune composition, metabolic state, and innate ...

Recreating tumour tissue in the laboratory as realistically as possible and developing new approaches for personalised cancer medicine: Starting in spring 2026, a total of 20 doctoral students in the ...

Memorial Sloan Kettering Cancer Center researchers continued to make strides against cancer in 2025. Learn about some of ...

The European Research Council (ERC) has announced the results of its 2025 Consolidator Grant call, selecting two projects led ...

ION, LLC, a health-tech startup based in Tampa, FL, today announced a collaborative project with the Infectious Diseases Division at Mayo Clinic Florida funded through the Mayo Clinic Advanced ...

Take a look back into biotech in 2025 as the year is closing - from GLP-1s to radiopharmaceuticals and neuroplastogens.

Indivumed, of Hamburg, Germany, is no stranger to cancer-centered collaborations; in August 2021, the company announced a ...

Trethera Corporation ('Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...

In the world of luxury retreats, a select few players are combining evidence- backed longevity protocols with gentle, ...